- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Chronic Obstructive Pulmonary Disorder in United Kingdom
Total 6167 results
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited Kingdom
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited Kingdom
-
AstraZenecaQuintiles, Inc.Completed
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)Colombia, India, Korea, Republic of, Poland, Croatia, Estonia, Hungary, United Kingdom, Israel, Latvia, Turkey, Argentina, Panama, Mexico, Russian Federation, Serbia, Slovenia
-
Sunovion Respiratory Development Inc.CompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
University of California, San FranciscoPatient-Centered Outcomes Research InstituteCompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
Edmond PharmaUnknownChronic Obstructive Pulmonary Disease (COPD)Belgium, Bulgaria, Czech Republic, Denmark, France, Italy, Poland, Romania, Slovakia, United Kingdom
-
Nephron Pharmaceuticals CorporationRho, Inc.CompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
Turino, Gerard, M.D.National Heart, Lung, and Blood Institute (NHLBI)CompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
VA Office of Research and DevelopmentCompletedHeart Failure | Chronic Obstructive Pulmonary Disease (COPD)United States
-
EmphycorpCellular Sciences, inc.Completed
-
NYU Langone HealthCompleted
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseGermany, Belgium, Spain, Canada, United Kingdom
-
Mylan Inc.Theravance BiopharmaCompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Austria, Belgium, Canada, France, Germany, Italy, Netherlands, South Africa, Spain, United Kingdom
-
Pulmonx CorporationCompletedPulmonary EmphysemaUnited Kingdom, Switzerland, Germany
-
SanofiRegeneron PharmaceuticalsRecruitingChronic Obstructive Pulmonary DiseaseUnited States, Netherlands, Belgium, Denmark, Germany, United Kingdom, Brazil
-
DeyCompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
Royal Brompton & Harefield NHS Foundation TrustCompletedHeterogeneous EmphysemaUnited Kingdom
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)United States, Canada, Germany, Argentina, Bulgaria, Poland, Turkey, Mexico, United Kingdom
-
Theravance BiopharmaGlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited Kingdom
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)France, Germany, United Kingdom, United States, Australia, Austria, Brazil, Hungary, New Zealand, Romania, Russian Federation
-
Portsmouth Hospitals NHS TrustPfizerCompletedPulmonary Disease, Chronic ObstructiveUnited Kingdom
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited Kingdom, Netherlands
-
NovartisCompletedChronic Obstructive Pulmonary Disease (COPD)United States, Spain, Turkey, France, Netherlands, Germany
-
MedImmune LLCCompletedChronic Obstructive Pulmonary DiseaseUnited States, Bulgaria, Czech Republic, Poland, United Kingdom, Philippines, Latvia, Lithuania, Ukraine, Hungary
-
Mylan Inc.Theravance BiopharmaCompletedChronic Obstructive Pulmonary Disease, COPD | Low Peak Inspiratory Flow Rate (PIFR)United States
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseRomania, Lithuania, Canada, France, Hungary, India, South Africa, Korea, Republic of, Latvia, United Kingdom
-
AstraZenecaActive, not recruitingChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
AstraZenecaActive, not recruitingChronic Obstructive Pulmonary Disease (COPD)United States, Denmark, Italy, United Kingdom, Canada, Germany, Turkey, Argentina, South Africa, Spain, Poland, Bulgaria, Mexico, Netherlands
-
Johns Hopkins UniversityNational Heart, Lung, and Blood Institute (NHLBI)Recruiting
-
Life Detection TechnologiesRoyal Free Hospital NHS Foundation TrustNot yet recruitingCOPD ExacerbationUnited Kingdom
-
University of LeicesterUniversity Hospitals, LeicesterCompletedPulmonary Disease, Chronic Obstructive | AsthmaUnited Kingdom
-
Johns Hopkins UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedChronic Obstructive Pulmonary DiseaseUnited States
-
OhioHealthCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
University of PittsburghCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Breathe Technologies, Inc.CompletedChronic Obstructive Pulmonary DiseaseUnited States
-
A.T. Still University of Health SciencesAmerican Osteopathic AssociationWithdrawnChronic Obstructive Pulmonary DiseaseUnited States
-
University of Colorado, DenverCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Johns Hopkins UniversityRecruitingCOPD, Chronic Obstructive Pulmonary DiseaseUnited States
-
University of MichiganCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
KU LeuvenUniversity of Zurich; University Medical Center Groningen; University of Athens; University of Edinburgh and other collaboratorsCompletedPulmonary Disease, Chronic ObstructiveNetherlands, United Kingdom, Belgium, Greece, Switzerland
-
Boston Scientific CorporationPneumRx, Inc.Completed
-
VA Office of Research and DevelopmentCompletedTreatment of Chronic Obstructive Pulmonary DiseaseUnited States
-
AstraZenecaCompletedA Trial Assessing LAS34273 in Moderate to Severe Stable Chronic Obstructive Pulmonary Disease (COPD)Chronic Obstructive Pulmonary Disease (COPD)Andorra, Austria, Belgium, Bulgaria, Czech Republic, Denmark, France, Germany, Hungary, Italy, Netherlands, Poland, Romania, Russian Federation, Spain, United Kingdom
-
University of California, San FranciscoNational Heart, Lung, and Blood Institute (NHLBI)RecruitingCOPD (Chronic Obstructive Pulmonary Disease)United States
-
University of Alabama at BirminghamWithdrawnChronic Obstructive Pulmonary DiseaseUnited States
-
University of MinnesotaVeterans Medical Research Foundation; Flight Attendant Medical Research InstituteCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Johns Hopkins UniversityNational Institute of Environmental Health Sciences (NIEHS)CompletedChronic Obstructive Pulmonary DiseaseUnited States